Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Stock Movers: Intel, ServiceNow, West Pharma
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
BridgeBio Pharma: Genetic Disease Specialist Is Thriving - I'm Upgrading To Buy (BBIO)
BridgeBio Pharma, Inc. has surged 130% since last year, now trading at a $14.4bn market cap, driven by optimism around its pipeline and ATTR-CM drug Attruby. Attruby posted $362m in 2025 sales but faces stiff competition from Pfizer and Alnylam…
Will bargain-basement telehealth visits help pharma drive drug scripts?
The little pink pill recently got a retail boost. Addyi, a drug that treats low libido in premenopausal women, has been on the market for more than a decade after a controversial approval. But in December the Food and Drug Administration expanded…
Pharma lifts Nifty off lows as crude oil, geopolitics keep markets under pressure at midday
Markets were trading sharply lower at midday on Friday, April 23, 2026, though selective buying in pharma and energy stocks helped indices recover from their worst levels of the session. The BSE Sensex was down ₹710.66 or 0.91 per cent at…
Stock markets dive 790 pts in early trade
Benchmark indices Sensex and Nifty tumbled in early trade on Friday as surging oil prices and unabated foreign fund outflows unnerved investors. Weakness in IT stocks and a negative trend in global markets also weighed on investor sentiment. The…
The big losers at the markets today
The 50-share NSE Nifty dropped 205.05 points, or 0.84 per cent, to end at 24,173.05. From the Sensex pack, Trent, Bajaj Finserv, Tech Mahindra, Mahindra & Mahindra, Infosys and HDFC Bank were among the major laggards. In contrast, Adani Ports…
Indian Stock Market Plunge: Oil Prices, FII Outflows & Geopolitical Tensions Drive Sell-off
Indian benchmark indices Sensex and Nifty plummeted in early trade, reflecting investor anxiety over surging global oil prices, sustained foreign fund outflows, and ongoing geopolitical tensions in West Asia. Benchmark indices Sensex and Nifty…
Atsushi Kitamura : Leading With Reality, Discipline, And Courage
Atsushi Kitamura, CFO of Astellas Pharma, oversees finance for one of Japan's leading global pharmaceutical companies. Atsushi Kitamura is the CFO of Astellas Pharma, a global life sciences company committed to turning innovative science into VALUE…
From Covid to Hormuz, what has Switzerland learned about drug shortages?
Suiza ante un suministro frágil de medicamentos en plena crisis internacional Cadeias globais em crise ameaçam remédios essenciais na Suíça بين كوفيد…
Nifty Prediction Today - April 24, 2026: Nifty futures: Bears gaining traction
Nifty 50 began today's session lower at 24,101 compared to yesterday's close of 24,173. The index slipped further after opening and is now trading at 23,950, down 0.9 per cent so far today. The advance/decline ratio stands at 10/40, showing a…
Stock markets tumble on surging oil prices, foreign fund outflows
Benchmark indices Sensex and Nifty tumbled in early trade on Friday (April 24, 2026) as surging oil prices and unabated foreign fund outflows unnerved investors. Weakness in IT stocks and a negative trend in global markets also weighed on investor…
Indian Stock Markets Fall: Sensex Dips 852 Points as Crude Oil Hits $100 Amid US-Iran Tensions
Indian stock markets witnessed a significant downturn for the second day, with the Sensex plummeting over 850 points, as crude oil prices surged past $100 per barrel amidst escalating US-Iran geopolitical tensions and persistent foreign fund…
Sensex tanks 852 pts, crude hits $100 amid war
Stock markets fell for the second consecutive day on Thursday, with the benchmark Sensex tumbling 852.49 points, as crude oil prices once again breached the USD 100 per barrel mark amid stalled US-Iran negotiations. Sustained foreign fund outflows…
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump. The biotech company will also offer the first hearing-loss gene therapy for free to eligible U.S. patients following regulatory approval of…
Thermo Fisher (TMO) Q1 2026 Earnings Transcript
Thursday, Apr. 23, 2026 at 8:30 a.m. ET Chairman and Chief Executive Officer — Marc N. Casper Senior Vice President and Chief Financial Officer — Stephen Williamson Vice President, Investor Relations — Rafael Tejada Need a…
Receive a Daily briefing on Pharma Industry News
Get Started